Acquisition Announced
LEO Pharma acquisition of Replay
US$50m consideration
Announced May 2026
Advisers
Replay
Target
Not disclosed
LEO Pharma
Acquirer
- Legal adviser
- Latham & Watkins

Team: David Brown, Marc Granger, Samantha Wheeler, Jane Lee, Aaron Gardner, Oliver Mobasser, Luke Nauth, Matthew Conway, Rebecca Fishbein, Andrea Ramezan-Jackson, Eni Kassim, Roger Chin, Cecelia Bain, Stephanie Fontanes, Eveline Van Keymeulen, Jeanne Fabre, Elizabeth Richards, Evan Miller, Patrick English, Nathaniel Amann, Jim Barker, Jana Dammann de Chapto, Enno Mensching, Andrew Galdes, Ankita Satpathy, Joseph Bargnesi, Capri Gaines, Aaron Potash, Tal Carmeli, Gina Kwon, Heather Deixler, Zac Alpert, Sarah Zahedi
- Target
- Replay
- Acquirer
- LEO Pharma
- Target based in
- United States (unverified)
- Buyer based in
- Denmark
- Sector
- Biotech
- Tags
- Biotech, Dermatology, Rare Disease
In the league tables
Similar deals
- BioMarin Pharmaceutical acquisition of Alesta Therapeutics Aug 2026 · US$275m · Biotech
- LEO Pharma acquisition of global rights for MT-7117 (dersimelagon) Aug 2026 · US$435m · Pharma
- Werewolf Therapeutics and Ambros Therapeutics merger Aug 2026 · US$500m · Biotech
- BioCryst Pharmaceuticals acquisition of Astria Therapeutics Oct 2025 · US$700m · Biotech
- Jazz Pharmaceuticals acquisition of Actio Biosciences Aug 2026 · US$820m · Biotech